<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5-pharmaceuticals-13-00464">
 <label>5.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Andre</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Zielinski</surname>
    <given-names>C.C.</given-names>
   </name>
  </person-group>
  <article-title>Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents</article-title>
  <source>Ann. Oncol. Off. J. Eur. Soc. Med Oncol.</source>
  <year>2012</year>
  <volume>23</volume>
  <issue>Suppl. 6</issue>
  <fpage>vi46</fpage>
  <lpage>vi51</lpage>
  <pub-id pub-id-type="doi">10.1093/annonc/mds195</pub-id>
 </element-citation>
</ref>
